ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors ...Middle East

GHENT, Belgium, Nov. 3, 2020 /PRNewswire/ -- ExeVir, which is developing nanobody therapies providing broad protection against viral infections, including a lead candidate for coronaviruses, today announced that Michel Kazatchkine and Stef Heylen have been appointed to the Board. Both...

Read More Details
Finally We wish PressBee provided you with enough information of ( ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors )

Also on site :

• Couple Bring Cat To Vet, Realize Something Heartbreaking Once They Arrive
• Ukrainian teachers told to pretend they can’t speak Russian
• Kylie Jenner’s Stunning European Vacation Snapshots Are Giving Us Major Life Goals Envy